Sponsor Pipeline

Linhui Peng Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07267806 Camrelizumab and Apatinib With or Without FOLFOX Chemotherapy for Advanced HCC Hepato Cellular Carcinoma (HCC) Recruiting
Disease Areas
Liver Cancer (1)
Get alerts when Linhui Peng's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free